215 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
of Common Stock reserved for issuance pursuant to our 2016 Employee Stock Purchase Plan;
250,000 shares of Common Stock reserved for issuance upon … sites or our third-party manufacturers may encounter difficulties in production.
Risks Related to Employee Matters, Managing Growth and Other Risks
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
properties, or any officer, director or employee of the Company or any of its Subsidiaries acting in his or her capacity as an officer, director … or employee, before or by any federal, state, county, local or foreign court, arbitrator, governmental or administrative agency, regulatory authority
8-K
EX-10.1
uletdbp jhds
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
8-K
EX-10.2
4cc2pzay8o2xl9 g6tz6
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
POS AM
jz45u6m5xewz13rkfk
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
gk0jw
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
S-8
9dbah9ddc03y6lxi19ky
29 Feb 24
Registration of securities for employees
5:06pm
S-8
EX-5.1
nd9qiigw8b6ound8
29 Feb 24
Registration of securities for employees
5:06pm
S-8
qpp90
29 Feb 24
Registration of securities for employees
5:06pm